JOHN E STANBACK

Allopathic & Osteopathic Physicians|Family Medicine COLUMBUS, MS NPI 1629034764

General Payments — all program years on this page

$5,807.59

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 405
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $255.25 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $255.2515

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $100.156
Phathom Pharmaceuticals, Inc. $71.434
ABBVIE INC. $33.762
Novo Nordisk AS $29.492
Amgen Inc. $20.421

By program year

Program yearAmountRecords
2018 $1,074.1682
2019 $980.2571
2020 $745.1358
2021 $898.1463
2022 $1,122.3270
2023 $732.3446
2024 $255.2515

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097557583 Novo Nordisk Inc $14.35 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097656982 Novo Nordisk Inc $15.14 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104222015 AstraZeneca Pharmaceuticals LP $16.88 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104376893 AstraZeneca Pharmaceuticals LP $18.44 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104688606 AstraZeneca Pharmaceuticals LP $17.63 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104699599 AstraZeneca Pharmaceuticals LP $14.78 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104764210 AstraZeneca Pharmaceuticals LP $15.72 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105445200 AstraZeneca Pharmaceuticals LP $16.70 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106153317 ABBVIE INC. $17.70 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106153319 ABBVIE INC. $16.06 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111715600 Amgen Inc. $20.42 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151129477 Phathom Pharmaceuticals, Inc. $18.87 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151129479 Phathom Pharmaceuticals, Inc. $19.07 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151129481 Phathom Pharmaceuticals, Inc. $17.68 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151129483 Phathom Pharmaceuticals, Inc. $15.81 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.